Pharmacy group launches website
The Senior Care Pharmacy Coalition (SCPC), launched in January, has announced its new website.
“Our mission is to help ensure lawmakers, regulators, staff and the broader healthcare policy community understand why independent long-term care (LTC) pharmacies are increasingly important to seniors’ care, the significant difference between retail and LTC pharmacies and the unique impact of policy challenges on this crucial element of our healthcare delivery system,” SCPC President and CEO Alan G. Rosenbloom said in a statement.
The SCPC represents companies that own and operate independent LTC pharmacies in 40 about states, serving more than 325,000 residents in skilled nursing centers and assisted living communities. The group’s issue agenda, Rosenbloom said, is guided by these overarching principles:
- Clinical efficacy and achieving optimal patient outcomes;
- Pricing transparency and marketplace equity;
- Regulatory efficiency, effectiveness and fairness; and
- Policy prescriptions that anticipate and act on future trends related to our LTC and post-acute care populations.
Within this framework, SCPC’s current focus is on these four issues:
- Maximum allowable cost pricing,
- Medicare Part D lock-in,
- Drug Enforcement Agency relationships and
- Protecting 2016 daily dispensing fee rule implementation.
Recent Posts
-
Senior Care Pharmacy Coalition Opposes CMS Final Rule on Minimum Staffing Standards for LTC Facilities
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy sector, released a statement today regarding its opposition to the Centers for Medicare & Medicaid Services (CMS) final rule on minimum staffing standards for long-term care (LTC) facilities.
-
Senior Care Pharmacy Coalition Shares Comments with CMS Regarding Medicare Part D Restructuring Guidance: “Smoothing Provisions”
SCPC filed comments with CMS in response to their guidance on the implementation of the Medicare Part D restructuring portion of the Inflation Reduction Act (IRA).
-
Drug pricing efforts threaten ‘very existence’ of LTC pharmacies: reps
President Biden in his State of the Union address last week vowed to end “Big Pharma’s” grip on prescription drug pricing and cut costs for seniors and taxpayers by another $200 million.
But the president’s plans to expand his administration’s first-ever Medicare drug price negotiations could spell big trouble for the pharmacists who support seniors living in long-term care settings, advocates warned in response.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.